Skip to content

Metatarsal Phalangeal Joint Deformity Progression - R01

Muscle, Joint and Movement Deterioration Contributing to Neuropathic Forefoot Deformity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02616263
Enrollment
60
Registered
2015-11-26
Start date
2016-03-31
Completion date
2021-06-29
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus (DM)

Brief summary

The purpose of this research study is to determine the relationships between foot muscle, foot motion, and toe deformity. Results from this investigation will help the investigators to understand what contributes to foot deformities and the role of the foot muscles in the development of foot deformities. This could potentially guide treatment options focusing on strengthening the foot muscles to prevent or reduce the risk of developing a foot deformity.

Detailed description

The long term goal of this research is to reduce the incidence of lower extremity amputation in people with diabetes mellitus and peripheral neuropathy. It is hypothesized that muscle, joint, and movement deterioration associated with diabetes and peripheral neuropathy contribute to metatarsophalangeal joint (MTPJ) hyperextension deformity. MTPJ deformity results in excessive plantar stress on the insensitive forefoot, leading to ulceration and amputation. However, the specific cause of MTPJ deformity is not clear. The overall goal of this proposal is to identify the causes of MTPJ deformity and examine the ability of a targeted foot specific intervention to de-couple diabetes related mechanisms from MTPJ deformity and progression, following participants for 3 years. The investigators hypothesize that the cause of MTPJ deformity is an interaction of the accumulation of advanced glycation end products, muscle deterioration, limited joint mobility and compensatory movement strategies. The specific aims are to determine: 1. relationships between advanced glycation end products, intrinsic foot muscle volume, limited ankle dorsiflexion joint mobility, MTPJ hyperextension movement pattern, and MTPJ alignment; 2. estimate the effect of a foot specific intervention on the MTPJ extension alignment and 3. determine progression of MTPJ deformity and the predictors of progression over three years. The following will be collected on participants with diabetes mellitus and peripheral neuropathy and monitored over three years to understand the causes and progression of MTPJ deformity: 1. Skin intrinsic florescence to measure advanced glycation end product accumulation which increases collagen cross-linking and is associated with peripheral neuropathy, limited joint mobility, and muscle deterioration. 2. Magnetic resonance images to measure intrinsic foot muscle deterioration that precedes extrinsic foot muscle deterioration as a result of distal to proximal peripheral neuropathy. The muscle imbalance of weak intrinsic foot muscles, the only muscles able to flex the MTPJ, in the presence of relatively stronger extrinsic toe extensors, results in a force couple that hyperextends the MTPJ. 3. Kinematic and computed tomography measurement of foot and ankle joint positions to examine mobility and movement patterns that contribute to repeated and extreme MTPJ hyperextension during daily activities. The investigators believe advanced glycation end products lead to limited ankle joint dorsiflexion. As a result, there is increased reliance on the extensor digitorum longus to assist in dorsiflexing the stiff ankle joint during activities like sit to stand. This study will have profound implications for reducing risk for skin breakdown and amputation by helping to understand and treat the causes of acquired neuropathic foot deformities. A successful foot specific intervention that improves MTPJ alignment will provide a non-invasive option to halt or slow the cascade of events leading to major lower extremity amputation, while improving function and minimizing disability.

Interventions

Sponsors

Washington University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Type 2 Diabetes Mellitus (DM) * Diabetic peripheral neuropathy

Exclusion criteria

* active plantar ulcers, unable to ambulate or complete required testing, anyone who have amputations of their lower extremity (\>1 toe), weigh more than 400 lbs, pregnant, have metal implants or pace makers (incompatible with MRI), greater than 75 years old, Subjects with other causes of PN (lumbar radiculopathy, microvascular disease, alcoholic/HIV/chemotaxic neuropathy), on dialysis, with peripheral arterial disease (ABI\<0.9 or \>1.3), with fixed MTPJ deformity (excursion \<30 degrees active/passive), acute shoulder pain or disability that would prevent participation in shoulder specific intervention (i.e. severe shoulder pain \>6/10, rotator cuff tear, upper extremity surgery, thoracic outlet syndrome);

Design outcomes

Primary

MeasureTime frameDescription
Change in Metatarsal Phalangeal Joint Angle (Degrees) in People With Diabetes From Baseline and at a 3-year PeriodThree yearsThe angle between the 2nd metatarsal and the proximal phalanx will be measured at baseline and again at the 3-years

Countries

United States

Participant flow

Participants by arm

ArmCount
Foot Intervention
The intervention is a progressive, home based exercise program aimed to increase ankle and foot plantarflexion muscle strength, increase ankle dorsiflexion and toe flexion range of motion, and to retrain individuals to dorsiflex the ankle while keeping the toes in a neutral position. A trained physical therapist with experience working with older adults with diabetes and foot specific complications will monitor and progress the exercise program assuring participant safety and maximizing exercise benefit. Foot exercise
29
Shoulder Intervention
Participants will be trained in a progressive home exercise program that includes passive stretching of end range shoulder flexion and external rotation and a tailored dose of active shoulder motion. Shoulder exercise
31
Total60

Withdrawals & dropouts

PeriodReasonFG000FG001
1.5 Year to 3+ Year Follow upWithdrawal by Subject42
6 Month to 1.5 YearDeath10
6 Month to 1.5 YearLost to Follow-up02
6 Month to 1.5 YearWithdrawal by Subject11
Baseline to 6 Month (Intervention Phase)Lost to Follow-up10
Baseline to 6 Month (Intervention Phase)Withdrawal by Subject03

Baseline characteristics

CharacteristicFoot InterventionShoulder InterventionTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
20 Participants19 Participants39 Participants
Age, Categorical
Between 18 and 65 years
9 Participants12 Participants21 Participants
Age, Continuous67.48 years
STANDARD_DEVIATION 8.05
66.55 years
STANDARD_DEVIATION 4.14
67 years
STANDARD_DEVIATION 6.3
Foot Joint Deformity
2nd Metatarsophalangeal Joint Hyperextension
54.7 Degrees
STANDARD_DEVIATION 12.3
51.4 Degrees
STANDARD_DEVIATION 13.3
53.0 Degrees
STANDARD_DEVIATION 12.8
Foot Joint Deformity
Calcaneal Pitch
21.5 Degrees
STANDARD_DEVIATION 6.6
18.5 Degrees
STANDARD_DEVIATION 5.3
20.0 Degrees
STANDARD_DEVIATION 6.1
Race/Ethnicity, Customized
Hispanic or Latino
1 Participants0 Participants1 Participants
Race/Ethnicity, Customized
Not Hispanic or Latino
26 Participants27 Participants53 Participants
Race/Ethnicity, Customized
Unknown or not reported
2 Participants4 Participants6 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
6 Participants10 Participants16 Participants
Race (NIH/OMB)
More than one race
2 Participants0 Participants2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
21 Participants21 Participants42 Participants
Region of Enrollment
United States
29 participants31 participants60 participants
Sex: Female, Male
Female
15 Participants19 Participants34 Participants
Sex: Female, Male
Male
14 Participants12 Participants26 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
1 / 290 / 31
other
Total, other adverse events
12 / 2919 / 31
serious
Total, serious adverse events
0 / 290 / 31

Outcome results

Primary

Change in Metatarsal Phalangeal Joint Angle (Degrees) in People With Diabetes From Baseline and at a 3-year Period

The angle between the 2nd metatarsal and the proximal phalanx will be measured at baseline and again at the 3-years

Time frame: Three years

Population: 23 participants in each group completed 3 year follow up testing (average follow up time was 3.6 yrs due to COVID pause in human research testing) to assess the effect of the foot intervention on metatarsophalangeal joint extension alignment.

ArmMeasureValue (MEAN)Dispersion
Foot InterventionChange in Metatarsal Phalangeal Joint Angle (Degrees) in People With Diabetes From Baseline and at a 3-year Period0.8 degreesStandard Deviation 9.3
Shoulder InterventionChange in Metatarsal Phalangeal Joint Angle (Degrees) in People With Diabetes From Baseline and at a 3-year Period-0.1 degreesStandard Deviation 8.2

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026